A new chapter for research and clinical innovation in NSW
The launch of the NSW Health Research and Innovation Strategy 2025–2030 marks a significant step toward creating a dynamic, collaborative ecosystem that delivers better health outcomes for our communities. Deputy Secretary of the Clinical Innovation and Research Division at the NSW Ministry of Health, Dr Jean-Frédéric Levesque, discusses how the Strategy will provide a roadmap for researchers, clinicians and health leaders. |
| |
|
|
Showcasing Australia’s collaborative approach to research at BIO 2025
In June, the Office for Health and Medical Research highlighted Australia’s collaborative research culture and hosted a breakfast panel at the 2025 BIO International Convention in Boston, USA. Led by Anne O’Neill, Director of Commercialisation and Strategic Partnerships at the Office, the panel explored emerging advances in proteomics and genomics in oncology. The 2025 NSW Health and Medical Research Prospectus was launched at the event. It showcases NSW’s strengths and capabilities in health and medical research.
| |
|
NSW Health hosts Clinical Trials Summit to strengthen partnerships
On 20 May, NSW Health hosted the Clinical Trials Summit at Parliament House to coincide with International Clinical Trials Day. The event brought together over 100 strategic leaders and national organisations involved in clinical trials, representing diverse sectors across the system. The Summit provided clear input into NSW Health’s clinical trials programs and helped clarify roles and responsibilities of other organisations in shaping a stronger, more connected clinical trials ecosystem.
|
| |
|
|
Connecting with medtech leaders at the 2025 ARCS Conference Thank you to everyone who visited our booth at the 2025 ARCS Conference. We were pleased to share information about our programs, including clinicaltrialsNSW, the Research Ethics and Governance Unit and the Clinical Trials Management System. The annual conference fosters a collaborative environment for the medical technology sectors in Australia and presents an exciting opportunity to connect with industry leaders. | |
|
Applications open for Commercialisation Training Program One Day Seminars
The NSW Health Commercialisation Training Program is free for NSW-based participants and designed to help you turn your health tech innovation into real-world impact. The One Day Seminar series covers four essential topics in commercialisation: intellectual property, regulatory affairs, clinical trials and navigating the healthcare system. Each session offers a clear overview and practical guidance from industry experts to support your innovation journey. |
| |
|
|
The NSW Health Commercialisation Training Program: turning ideas into impact
A recent evaluation of the Program has shown it delivers strong returns - generating $20.53 for $1 invested. Since launching in 2014, the Program has equipped NSW researchers and entrepreneurs with the skills to translate medical discoveries into real-world products and successful companies. As the first program of its kind in Australia, it has since inspired similar initiatives across the country. | |
|
17 July
National Critical Research Infrastructure Initiative - 2024 Clinical Trial Enabling Infrastructure (closing)
MRFF
Find out more |
17 July
Navigating Health Research Webinar: Project Management Tips to Supercharge Your Clinical Trial Operations
Sydney Health Partners
Register now |
23 July
Early to Mid-Career Researchers Initiative – 2025 Early to Mid-Career Researchers Grant Opportunity
MRFF
Find out more |
24 July
ReConX 2025 - Building Researcher-Consumer Connections
Sydney Health Partners
Register now
|
1 - 3 August
PSA25 National Conference
Pharmaceutical Society of Australia
Register now
|
|
|
The Office for Health and Medical Research sits in the Clinical Innovation and Research Division of NSW Health. The Office works with research communities, universities and business to promote growth and innovation in health and medical research to achieve better outcomes for patients and establish NSW as a global centre of excellence.
|
|
|
|
